Brazil: Regulatory Agency Gets Authority to Deny Patents

Posted 04 June 2012 | By Ansis Helmanis 

As the result of a new patent review process, Brazilian regulatory authority Anvisa is being given the authority to deny the grant of a patent for a medical product.

The agency can make deny a decision to grant a patent if it determines the patent would impede universal access to medicines-a Brazilian constitutional right. This so-called right of "prior consent" by Anvisa would be binding on Brazil's Patent and Trademark Office (INPI).


Read more:

Patent Review Process Overview

More Breaking News from RegLink


Tags: Patent, brazil

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe